Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Gordon

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
The New England Journal of Medicine|June 30, 2000
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposisG Steinbach, P M Lynch, R K Phillips, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1997
Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomesL P Jacobson, B C Zhang, Y R Zhu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 1998
Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkersT W Kensler, X He, M Otieno, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1997
Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of ChinaB C Zhang, Y R Zhu, J B Wang, et al.
Journal of the National Cancer Institute|August 21, 2003
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal womenT J Key, P N Appleby, G K Reeves, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
The New England Journal of Medicine|June 30, 2000
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposisG Steinbach, P M Lynch, R K Phillips, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1997
Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomesL P Jacobson, B C Zhang, Y R Zhu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 1998
Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkersT W Kensler, X He, M Otieno, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1997
Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of ChinaB C Zhang, Y R Zhu, J B Wang, et al.
Journal of the National Cancer Institute|August 21, 2003
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal womenT J Key, P N Appleby, G K Reeves, et al.
Pageof 7